SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000921895-17-000279
Filing Date
2017-02-10
Accepted
2017-02-10 17:27:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 sc13ga110109002_02102017.htm SC 13G/A 70105
  Complete submission text file 0000921895-17-000279.txt   71635
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Subject) CIK: 0001388320 (see all company filings)

IRS No.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-82467 | Film No.: 17594800
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1275 YORK AVE. NEW YORK NY 10065
Business Address 1275 YORK AVE. NEW YORK NY 10065 212-639-2000
Memorial Sloan-Kettering Cancer Center (Filed by) CIK: 0001566787 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NY
Type: SC 13G/A